Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22


Obesity and 1-Year Mortality in Adults After Sepsis: A Systematic Review.

Robinson J, Swift-Scanlan T, Salyer J.

Biol Res Nurs. 2019 Sep 18:1099800419876070. doi: 10.1177/1099800419876070. [Epub ahead of print]


Metabolomic Differentials in Women With and Without Fibromyalgia.

Menzies V, Starkweather A, Yao Y, Thacker LR 2nd, Garrett TJ, Swift-Scanlan T, Kelly DL, Patel P, Lyon DE.

Clin Transl Sci. 2019 Aug 14. doi: 10.1111/cts.12679. [Epub ahead of print]


Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study.

Conway K, Edmiston SN, Parrish E, Bryant C, Tse CK, Swift-Scanlan T, McCullough LE, Kuan PF.

Breast Cancer Res Treat. 2017 Jun;163(2):349-361. doi: 10.1007/s10549-017-4178-8. Epub 2017 Mar 8.


Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.

Garcia-Bloj B, Moses C, Sgro A, Plani-Lam J, Arooj M, Duffy C, Thiruvengadam S, Sorolla A, Rashwan R, Mancera RL, Leisewitz A, Swift-Scanlan T, Corvalan AH, Blancafort P.

Oncotarget. 2016 Sep 13;7(37):60535-60554. doi: 10.18632/oncotarget.11142.


Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.

Conway K, Edmiston SN, Tse CK, Bryant C, Kuan PF, Hair BY, Parrish EA, May R, Swift-Scanlan T.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):921-30. doi: 10.1158/1055-9965.EPI-14-1228. Epub 2015 Mar 25.


Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer.

Stolzenburg S, Beltran AS, Swift-Scanlan T, Rivenbark AG, Rashwan R, Blancafort P.

Oncogene. 2015 Oct;34(43):5427-35. doi: 10.1038/onc.2014.470. Epub 2015 Feb 16.


Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors.

Hair BY, Troester MA, Edmiston SN, Parrish EA, Robinson WR, Wu MC, Olshan AF, Swift-Scanlan T, Conway K.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):580-6. doi: 10.1158/1055-9965.EPI-14-1017. Epub 2015 Jan 12.


Deconstructing breast cancer heterogeneity: clinical implications for women with Basal-like tumors.

Rattani NS, Swift-Scanlan T.

Oncol Nurs Forum. 2014 Nov 1;41(6):639-46. doi: 10.1188/14.ONF.639-646. Review.


DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.

Conway K, Edmiston SN, May R, Kuan PF, Chu H, Bryant C, Tse CK, Swift-Scanlan T, Geradts J, Troester MA, Millikan RC.

Breast Cancer Res. 2014 Oct 7;16(5):450. doi: 10.1186/s13058-014-0450-6.


Comprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulator.

Swift-Scanlan T, Smith CT, Bardowell SA, Boettiger CA.

BMC Med Genomics. 2014 Jan 24;7:5. doi: 10.1186/1755-8794-7-5.


Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns.

Bardowell SA, Parker J, Fan C, Crandell J, Perou CM, Swift-Scanlan T.

Breast Cancer Res Treat. 2013 Nov;142(2):365-80. doi: 10.1007/s10549-013-2738-0. Epub 2013 Nov 10.


Genetic polymorphisms regulating dopamine signaling in the frontal cortex interact to affect target detection under high working memory load.

Smith CT, Swift-Scanlan T, Boettiger CA.

J Cogn Neurosci. 2014 Feb;26(2):395-407. doi: 10.1162/jocn_a_00501. Epub 2013 Oct 21.


Vimentin DNA methylation predicts survival in breast cancer.

Ulirsch J, Fan C, Knafl G, Wu MJ, Coleman B, Perou CM, Swift-Scanlan T.

Breast Cancer Res Treat. 2013 Jan;137(2):383-96. doi: 10.1007/s10549-012-2353-5. Epub 2012 Dec 13.


Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort.

Swift-Scanlan T, Vang R, Blackford A, Fackler MJ, Sukumar S.

Cancer Biol Ther. 2011 May 15;11(10):853-65. Epub 2011 May 15.


Challenges in studying the etiology of breast cancer subtypes.

Troester MA, Swift-Scanlan T.

Breast Cancer Res. 2009;11(3):104. doi: 10.1186/bcr2323. Epub 2009 Jun 29.


Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid.

Fackler MJ, Malone K, Zhang Z, Schilling E, Garrett-Mayer E, Swift-Scanlan T, Lange J, Nayar R, Davidson NE, Khan SA, Sukumar S.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3306-10.


Two-color quantitative multiplex methylation-specific PCR.

Swift-Scanlan T, Blackford A, Argani P, Sukumar S, Fackler MJ.

Biotechniques. 2006 Feb;40(2):210-9.


Characterization of CTG/CAG repeats on chromosome 18: a study of bipolar disorder.

Swift-Scanlan T, Coughlin JM, Lan TH, Potash JB, Ingersoll RG, Depaulo R Jr, Ross CA, McInnis MG.

Psychiatr Genet. 2005 Jun;15(2):91-9.


Genome-wide scan of bipolar disorder in 65 pedigrees: supportive evidence for linkage at 8q24, 18q22, 4q32, 2p12, and 13q12.

McInnis MG, Lan TH, Willour VL, McMahon FJ, Simpson SG, Addington AM, MacKinnon DF, Potash JB, Mahoney AT, Chellis J, Huo Y, Swift-Scanlan T, Chen H, Koskela R, Stine OC, Jamison KR, Holmans P, Folstein SE, Ranade K, Friddle C, Botstein D, Marr T, Beaty TH, Zandi P, DePaulo JR.

Mol Psychiatry. 2003 Mar;8(3):288-98.


Genetic analysis of the (CTG)n NOTCH4 polymorphism in 65 multiplex bipolar pedigrees.

Swift-Scanlan T, Lan TH, Fallin MD, Coughlin JM, Potash JB, DePaulo JR, McInnis MG.

Psychiatr Genet. 2002 Mar;12(1):43-7.


Gene identification using exon amplification on human chromosome 18q21: implications for bipolar disorder.

Chen H, Huo Y, Patel S, Zhu X, Swift-Scanlan T, Reeves RH, DePaulo R Jr, Ross CA, McInnis MG.

Mol Psychiatry. 2000 Sep;5(5):502-9.


Full-genome scan for linkage in 50 families segregating the bipolar affective disease phenotype.

Friddle C, Koskela R, Ranade K, Hebert J, Cargill M, Clark CD, McInnis M, Simpson S, McMahon F, Stine OC, Meyers D, Xu J, MacKinnon D, Swift-Scanlan T, Jamison K, Folstein S, Daly M, Kruglyak L, Marr T, DePaulo JR, Botstein D.

Am J Hum Genet. 2000 Jan;66(1):205-15.

Supplemental Content

Loading ...
Support Center